HomeCASI • NASDAQ
Follow
CASI Pharmaceuticals Inc
Previous close
$3.00
Day range
$2.95 - $3.72
Year range
$1.85 - $8.48
Market cap
48.09M USD
Avg Volume
391.21K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 8.84M | -13.46% |
Operating expense | 10.44M | -15.28% |
Net income | -4.64M | 10.88% |
Net profit margin | -52.44 | -2.96% |
Earnings per share | -0.35 | 8.63% |
EBITDA | -4.64M | 16.94% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 35.60M | 7.70% |
Total assets | 74.23M | -41.97% |
Total liabilities | 23.79M | -46.76% |
Total equity | 50.43M | — |
Shares outstanding | 13.38M | — |
Price to book | 1.40 | — |
Return on assets | -17.25% | — |
Return on capital | -25.16% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -4.64M | 10.88% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1991
Headquarters
Website
Employees
224